Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Armodafinil for Excessive Sleepiness in Shift Work Sleep Disorder
NCT00080288Phase 3Completed
- Sponsor
- Cephalon, Inc.
- Start
- Mar 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of armodafinil in shift work sleep disorder (SWSD), sponsored by Cephalon, Inc.. Started Mar 2004; status: completed.
02
Drugs
armodafinil
03
Conditions
shift work sleep disorder (SWSD)
Beyond the preview
Go deeper on NCT00080288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00080288.